Controversies in Parotid Surgery: Is There Evidence, Part 2

Monday, September 30, 2024

9:30 AM – 10:30 AM EDT

Location: MBCC, 209

CME/MOC Credit: 1

Disclosure(s):

Samir S. Khariwala, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Lisa Shnayder, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Carol M. Lewis, MD MPH:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Derrick T. Lin, MD, FACS:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: This panel addresses controversial, but commonly encountered, issues in the management of benign and malignant parotid disease. We will review the data regarding (1) capsular dissection for tumors; (2) superficial versus total parotidectomy for both primary malignancy and cutaneous metastases; (3) indications for neck dissection with primary parotid malignancy; (4) Management of the facial nerve in the setting of malignancy and (5) Complication rates and management. This session will allow for audience interaction and appeal to general otolaryngologists, academicians, and trainees, in addition to the head and neck oncological surgeon. This two hour panel presentation will cover the topics above using a combination of didactics, audience response queries, and case-based examples.

Learning Objectives:

Use an evidence-based framework to determine appropriate use of capsular dissection in parotid disease.
Understand indications for superficial vs total parotidectomy as well as the use of neck dissection in parotid malignancy.
Understand data-based approach for facial nerve management in malignancy and prevention/management of complications.

Moderator(s)

SK

Samir S. Khariwala, MD

Professor and Chair
University of Minnesota
Edina, MN, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
LS

Lisa Shnayder, MD

Professor
Kansas University Physicians Inc
Kansas City, KS, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Panelist(s)

CL

Carol M. Lewis, MD MPH

Professor
MD Anderson Cancer Center
Houston, TX, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
DL

Derrick T. Lin, MD, FACS

Chief, Division of Head and Neck Oncology
Massachusetts Eye and Ear
Boston, MA, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.